Meeting
2022 ASCO Annual Meeting
Predictors of differential outcomes according to response to induction chemotherapy in high-risk neuroblastoma.
Authors
Elizabeth Sokol
Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL
Elizabeth Sokol , Brian LaBarre , Arlene Naranjo , Navin R. Pinto , Susan G. Kreissman , Meaghan Granger , Julie R. Park , Rochelle Bagatell , Steven G. DuBois
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Pediatric Oncology
Track
Pediatric Oncology
Sub Track
Pediatric Solid Tumors
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 10032)
DOI
10.1200/JCO.2022.40.16_suppl.10032
Abstract #
10032
Poster Bd #
247
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Predictors of differential response to induction chemotherapy in high-risk neuroblastoma: A report from the Children's Oncology Group (COG).
First Author: Navin R. Pinto
Poster
2022 ASCO Annual Meeting
Clinical and biological features prognostic of survival after relapse of INRGSS-stage MS pattern neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
First Author: Kevin M. Campbell
Poster
2021 ASCO Annual Meeting
Predicting response to chemotherapy in neuroblastoma using deep learning: A report from the International Neuroblastoma Risk Group.
First Author: Siddhi Ramesh
Poster
2016 ASCO Annual Meeting
Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBL1/Siopen trial.
First Author: Ruth Ladenstein